Axsome Therapeutics (AXSM) Stock News
$AXSM · NASDAQ · HEALTHCARE · 2 stories in 30 days$138.05
1D −4.42%
BORSA has published 2 stories on Axsome Therapeutics (AXSM) in the past 30 days. BORSA’s news read on AXSM is bullish at 60/100, based on 2 company events over the past 7 days. Axsome Therapeutics’ next earnings report is scheduled for Monday, Nov 2 before the open.
The wire on $AXSM
newest first · updated · direct subject stories onlyAxsome Therapeutics: current cash sufficient to fund operations into cash flow positivity
Axsome Therapeutics stated its current cash position is enough to fund expected operations until the company reaches cash flow positivity. No further details on cash balance or timeline were provided.
bullish 70 · impact 40Axsome Therapeutics 3Q revenue $259.7 million
Axsome Therapeutics reported third-quarter revenue of $259.7 million. No further details on net income, earnings per share, or guidance were provided in the initial release.
neutral 50 · impact 30